Anti-angiogenic therapies in brain metastases

[1]  S. McGovern,et al.  Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases , 2017, Melanoma research.

[2]  F. Bonnetain,et al.  Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE) , 2017, Oncology.

[3]  P. Lockman,et al.  Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden , 2017, Front. Pharmacol..

[4]  M. Fabrini,et al.  Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature , 2017, Journal of clinical medicine research.

[5]  Alexander Radbruch,et al.  Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) , 2017, Neuro-oncology.

[6]  A. Ardavanis,et al.  Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. , 2016, Oncology letters.

[7]  S. Lim,et al.  Palliative Resection of Metastatic Brain Tumors Previously Treated by Stereotactic Radiosurgery , 2016, Brain tumor research and treatment.

[8]  J. Hainfellner,et al.  Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers , 2016, ESMO Open.

[9]  J. Trojan,et al.  Bevacizumab in Combination with Chemotherapy for Colorectal Brain Metastasis , 2016, Journal of Gastrointestinal Cancer.

[10]  W. Wick,et al.  Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma , 2016, Molecular Cancer Therapeutics.

[11]  T. Mikkelsen,et al.  Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases , 2015, Journal of Neuro-Oncology.

[12]  J. Pichler,et al.  Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases , 2015, Neuropathology and applied neurobiology.

[13]  J. Soria,et al.  Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study , 2015, Clinical Cancer Research.

[14]  L. Gras,et al.  REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  M. Preusser,et al.  Alleviation of Brain Edema and Restoration of Functional Independence by Bevacizumab in Brain-Metastatic Breast Cancer: A Case Report , 2014, Breast Care.

[16]  A. Ravaud,et al.  A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases. , 2014, Clinical genitourinary cancer.

[17]  Frank Winkler,et al.  Invasion patterns in brain metastases of solid cancers. , 2013, Neuro-oncology.

[18]  J. Villano,et al.  Bevacizumab and central nervous system (CNS) hemorrhage , 2013, Cancer Chemotherapy and Pharmacology.

[19]  L. Zini,et al.  Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? , 2012, Bulletin du cancer.

[20]  D. Schadendorf,et al.  Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. , 2012, European journal of cancer.

[21]  C. Porta,et al.  Sunitinib in metastatic renal cell carcinoma patients with brain metastases , 2011, Cancer.

[22]  T. Mikkelsen,et al.  Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. , 2010, The oncologist.

[23]  B. Besse,et al.  Bevacizumab Safety in Patients with Central Nervous System Metastases , 2009, Clinical Cancer Research.

[24]  M. Socinski,et al.  Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Sana Intidhar Labidi,et al.  Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series. , 2009, Clinical breast cancer.

[26]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[27]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.